These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28158181)

  • 21. Factor V east Texas variant causes bleeding in a three-generation family.
    Peterson JA; Gupta S; Martinez ND; Hardesty B; Maroney SA; Mast AE
    J Thromb Haemost; 2022 Mar; 20(3):565-573. PubMed ID: 34847292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity.
    MacDonald S; White D; Langdown J; Downes K; Thomas W
    Int J Lab Hematol; 2020 Jun; 42(3):246-255. PubMed ID: 32003946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-releasable and platelet pools of tissue factor pathway inhibitor in rabbits.
    Warn-Cramer BJ; Maki SL; Rapaport SI
    Thromb Haemost; 1993 Mar; 69(3):221-6. PubMed ID: 8470044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
    Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
    J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.
    Ellery PER; Hilden I; Sejling K; Loftager M; Martinez ND; Maroney SA; Mast AE
    Res Pract Thromb Haemost; 2018 Jan; 2(1):93-104. PubMed ID: 29354797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residues.
    Thomassen MCLGD; Bouwens BRC; Wichapong K; Suylen DP; Bouwman FG; Hackeng TM; Koenen RR
    J Thromb Haemost; 2023 May; 21(5):1214-1226. PubMed ID: 36716968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.
    Morizumi S; Hiramatsu Y; Matsuzaki K; Goto Y; Sato S; Abe M; Kato H; Matsubara M; Sakakibara Y
    J Card Surg; 2014 Jan; 29(1):35-40. PubMed ID: 24266905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effects of TFPI variants on thrombin and factor Xa generation in fibrinogen-deficient human plasma.
    Kaiser B; Jeske W; Hoppensteadt D; Fareed J
    Thromb Res; 1994 Dec; 76(6):561-8. PubMed ID: 7900103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
    Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.
    Undas A; Gissel M; Kwasny-Krochin B; Gluszko P; Mann KG; Brummel-Ziedins KE
    Thromb Haemost; 2010 Aug; 104(2):224-30. PubMed ID: 20593110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelets contain tissue factor pathway inhibitor-2 derived from megakaryocytes and inhibits fibrinolysis.
    Vadivel K; Ponnuraj SM; Kumar Y; Zaiss AK; Bunce MW; Camire RM; Wu L; Evseenko D; Herschman HR; Bajaj MS; Bajaj SP
    J Biol Chem; 2014 Nov; 289(45):31647-61. PubMed ID: 25262870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet tissue factor pathway inhibitor modulates intravascular coagulation.
    Maroney SA; Mast AE
    Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S21-2. PubMed ID: 22425319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential.
    Yamamoto J; Inoue N; Otsui K; Ishii H; Gorog DA
    Thromb Res; 2014 May; 133(5):919-26. PubMed ID: 24613697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels.
    Potze W; Arshad F; Adelmeijer J; Blokzijl H; van den Berg AP; Meijers JC; Porte RJ; Lisman T
    Br J Haematol; 2013 Sep; 162(6):819-26. PubMed ID: 23841464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
    Dahm A; Rosendaal FR; Andersen TO; Sandset PM
    Br J Haematol; 2006 Feb; 132(3):333-8. PubMed ID: 16409298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor.
    Bara L; Bloch MF; Zitoun D; Samama M; Collignon F; Frydman A; Uzan A; Bouthier J
    Thromb Res; 1993 Mar; 69(5):443-52. PubMed ID: 8388583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
    Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of different hormonal contraceptives on plasma levels of free protein S and free TFPI.
    Raps M; Helmerhorst FM; Fleischer K; Dahm AE; Rosendaal FR; Rosing J; Reitsma P; Sandset PM; van Vliet HA
    Thromb Haemost; 2013 Apr; 109(4):606-13. PubMed ID: 23407778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.